Efficacy and Safety of Bevacizumab-Combined Chemotherapy for Advanced and Recurrent Endometrial Cancer: A Systematic Review and Meta-analysis

BACKGROUND: Bevacizumab-combined chemotherapy is a new regimen for advanced/recurrent endometrial cancer. AIMS: To evaluate the efficacy and safety of bevacizumab-combined chemotherapy in advanced/recurrent endometrial cancer. STUDY DESIGN: Systematic review and meta-analysis. METHODS: Eligible stud...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Hui, Liang, Minglin, Min, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AVES 2021
Materias:
Systematic Review & Meta-analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909221/
https://www.ncbi.nlm.nih.gov/pubmed/33593716
http://dx.doi.org/10.5152/balkanmedj.2021.20121

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8909221/
https://www.ncbi.nlm.nih.gov/pubmed/33593716
http://dx.doi.org/10.5152/balkanmedj.2021.20121

Ejemplares similares